Run Lu
Impact in
- Biochemistry top 2%
- Amino Acid Enzymes and Metabolism
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Pharmacology 12
- Inflammatory mediators and NSAID effects 11
-
- Peroxisome Proliferator-Activated Receptors 5
- Ion Transport and Channel Regulation 3
- Co-authors
- Victor L. Schuster (14 shared papers)Yi Bao (7 shared papers)Naoaki KANAI (6 shared papers)Allan W. Wolkoff (4 shared papers)V. L. Schuster (6 shared papers)Brenda S. Chan (5 shared papers)Yi Bao (3 shared papers)Joseph Satriano (2 shared papers)
- Journals
- American Journal of Physiology-Renal Physiology (7 papers)Molecular Pharmacology (2 papers)Journal of Clinical Investigation (2 papers)Apmis (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Run Lu
26 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 89
- Biochemistry 208
- Oncology 619
- Pharmacology 369
- Clinical Biochemistry 110
- Pharmacology 113
Countries citing papers authored by Run Lu
This map shows the geographic impact of Run Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run Lu more than expected).
Fields of papers citing papers by Run Lu
This network shows the impact of papers produced by Run Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run Lu. The network helps show where Run Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Run Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 340 | |
| 2 | 1996 | 200 | |
| 3 | 1999 | 140 | |
| 4 | 2004 | 119 | |
| 5 | 2002 | 69 | |
| 6 | 1996 | 66 | |
| 7 | 1996 | 61 | |
| 8 | 2017 | 60 | |
| 9 | 1996 | 59 | |
| 10 | 2010 | 58 | |
| 11 | 1999 | 50 | |
| 12 | 2005 | 48 | |
| 13 | 2002 | 32 | |
| 14 | 1996 | 31 | |
| 15 | 1998 | 28 | |
| 16 | 1996 | 27 | |
| 17 | 1997 | 23 | |
| 18 | 2005 | 19 | |
| 19 | The Prostaglandin Transporter: Eicosanoid Reuptake, Control of Signaling, and Development of High-Affinity Inhibitors as Drug Candidates. | 2015 | 16 |
| 20 | 2023 | 11 |
About Run Lu
Run Lu is a scholar working on Pharmacology, Molecular Biology, Oncology, Genetics and Ecology, having authored 27 papers that have together received 1.5k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (11 papers), Drug Transport and Resistance Mechanisms (9 papers), Estrogen and related hormone effects (7 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Ion Transport and Channel Regulation (3 papers), Metabolism and Genetic Disorders (2 papers), Electrolyte and hormonal disorders (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Biochemistry (208 citations), Oncology (619 citations), Pharmacology (369 citations), Clinical Biochemistry (110 citations) and Pharmacology (113 citations). Run Lu has collaborated with scholars based in United States, China and France. Frequent co-authors include Victor L. Schuster, Yi Bao, Naoaki KANAI, Allan W. Wolkoff, V. L. Schuster, Brenda S. Chan, Yi Bao, Joseph Satriano, Michael L. Pucci and Norifumi Kanai. Their work appears in journals such as American Journal of Physiology-Renal Physiology, Molecular Pharmacology, Journal of Clinical Investigation, Apmis and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.